Huo, Jiandong https://orcid.org/0000-0002-7899-1815
Dijokaite-Guraliuc, Aiste
Nutalai, Rungtiwa
Das, Raksha
Zhou, Daming
Mentzer, Alexander J. https://orcid.org/0000-0002-4502-2209
Fry, Elizabeth E.
Mongkolsapaya, Juthathip
Ren, Jingshan
Stuart, David I.
Screaton, Gavin R.
Funding for this research was provided by:
Chinese Academy of Medical Sciences (2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002, 2018-I2M-2-002)
Wellcome Trust (101122/Z/13/Z)
Article History
Received: 1 August 2022
Accepted: 3 October 2022
First Online: 1 November 2022
Conflict of interest
: G.R.S. sits on the GSK Vaccines Scientific Advisory Board and is a founder member of RQ Biotechnology. Oxford University holds intellectual property related to SARS-CoV-2 mAb discovered in G.R.S’s laboratory. The University of Oxford has a partnership with AstraZeneca on coronavirus vaccine development.